Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities.
- DOI
- 10.3390/cancers18111744
- Published
- 2026 May 27
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18111744,
title = {Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities.},
author = {Schneider SA and D'Amora P and Evans SS and Kent P and Stockwell T and Bakaya VS and Bernard PJ and Francisco FR and Torres L and Henry J Jr and Silva IDCG and Nagourney RA},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18111744},
url = {https://doi.org/10.3390/cancers18111744}
}RIS
TY - JOUR TI - Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities. AU - Schneider SA AU - D'Amora P AU - Evans SS AU - Kent P AU - Stockwell T AU - Bakaya VS AU - Bernard PJ AU - Francisco FR AU - Torres L AU - Henry J Jr AU - Silva IDCG AU - Nagourney RA PY - 2026 JO - Cancers DO - 10.3390/cancers18111744 UR - https://doi.org/10.3390/cancers18111744 ER -
APA
SA, S., P, D., SS, E., P, K., T, S., VS, B., PJ, B., FR, F., L, T., Jr, H. J., IDCG, S., & RA, N. (2026). Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities.. Cancers. https://doi.org/10.3390/cancers18111744
Source records
- pubmed · retrieved 2026-09-26T06:53:56.612Z